Nuclear Receptor Agonists As Potential Differentiation Therapy Agents for Human Osteosarcoma

PURPOSE: This study was designed to investigate whether nuclear receptor agonists can be used as potential differentiation therapy agents for human osteosarcoma. EXPERIMENTAL DESIGN: Four osteosarcoma cell lines (143B, MNNG/HOS, MG-63, and TE-85) were treated with proliferator-activated receptor (PP...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Cancer Res
Egile Nagusiak: Haydon, Rex C., Zhou, Lan, Feng, Tao, Breyer, Benjamin, Cheng, Hongwei, Jiang, Wei, Ishikawa, Akira, Peabody, Terrance, Montag, Anthony, Simon, Michael A., He, Tong-Chuan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2002
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4527755/
https://ncbi.nlm.nih.gov/pubmed/12006550
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak